Antiphospholipid Antibodies and Malignancy

Hematology/Oncology Clinics of North America

Volumn 22, Issue 1, 2008, Pages 121-130

  Pham, Chi ^a   Shen, Yu Min ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; TUMOR ANTIGEN;

ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; CANCER REGRESSION; CANCER THERAPY; CARCINOID; CLINICAL FEATURE; COLON CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ACTIVITY; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERCOAGULABILITY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MONITORING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SOLID TUMOR; STOMACH CANCER; THROMBOEMBOLISM; THYROID CANCER; TREATMENT RESPONSE; TUMOR CELL; TUMOR IMMUNITY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; NEOPLASMS; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 38149119717     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2007.10.004     Document Type: Review

References (53)

1. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 2 (2006) 295-306
2. Passam F., and Krilis S. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 36 (2004) 129-138
3. Conley C.L. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31 (1952) 621-622
4. Cervera R., and Asherson R.A. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 207 1 (2003) 5-11
5. Matsuda J., Saitoh N., Gotoh M., et al. High prevalence of antiphospholipid antibodies and antithyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha. Am J Gastroenterol 90 7 (1995) 1138-1141
6. Prieto J., Yuste J.R., Beloqui O., et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 23 2 (1996) 199-204
7. Uthman I.W., and Gharavi A.E. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 31 4 (2002) 256-263
8. Naldi L., Locati F., Finazzi G., et al. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 75 11 (1995) 2784-2785
9. Gomez-Puerta J.A., Cervera R., Espinosa G., et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35 5 (2006) 322-332
10. Pugliese L.B.I., Pacifico E., Viola-Magni M., et al. Antiphospholipid antibodies in patients with cancer. Int J Immunopathol Pharmacol 19 4 (2006) 879-888
11. Vila P., Hernandez M.C., Lopez-Fernandez M.F., et al. Prevalence, follow-up, and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 72 2 (1994) 209-213
12. Sack Jr. G.H., Levin J., and Bell W.R. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 56 1 (1977) 1-37
13. Blom J.W., Doggen C.J., Osanto S., et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 6 (2005) 715-722
14. Levitan N., Dowlati A., Remick S.C., et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78 5 (1999) 285-291
15. White R.H., Chew H.K., Zhou H., et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 165 15 (2005) 1782-1787
16. Prandoni P., Lensing A.W., Buller H.R., et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327 16 (1992) 1128-1133
17. Nordstrom M., Lindblad B., Anderson H., et al. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 308 6933 (1994) 891-894
18. Gouin-Thibault I., Achkar A., and Samama M.M. The thrombophilic state in cancer patients. Acta Haematol 106 1-2 (2001) 33-42
19. Buller H.R., van Doormaal F.F., van Sluis G.L., et al. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 5 Suppl 1 (2007) 246-254
20. Kakkar A.K., Levine M.N., Kadziola Z., et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 22 10 (2004) 1944-1948
21. Klerk C.P., Smorenburg S.M., Otten H.M., et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23 10 (2005) 2130-2135
22. Lee A.Y., Rickles F.R., Julian J.A., et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 23 10 (2005) 2123-2129
23. Zuckerman E., Toubi E., Golan T.D., et al. Increased thromboembolic incidence in anticardiolipin-positive patients with malignancy. Br J Cancer 72 2 (1995) 447-451
24. Hanly J.G., Smith S.A., and Anderson D. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis. J Rheumatol 30 9 (2003) 1990-1993
25. Rand J.H., Wu X.X., Quinn A.S., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 163 3 (2003) 1193-1200
26. Giannakopoulos B., Passam F., Rahgozar S., et al. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 2 (2007) 422-430
27. Shi W., Krilis S.A., Chong B.H., et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 20 3 (1990) 231-236
28. Manoussakis M.N., Tzioufas A.G., Silis M.P., et al. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 69 3 (1987) 557-565
29. Schved J.F., Dupuy-Fons C., Biron C., et al. A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study. Haemostasis 24 3 (1994) 175-182
30. Armas J.B., Dantas J., Mendonca D., et al. Anticardiolipin and antinuclear antibodies in cancer patients-a case control study. Clin Exp Rheumatol 18 2 (2000) 227-232
31. Bairey O., Blickstein D., Monselise Y., et al. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma. Eur J Haematol 76 5 (2006) 384-391
32. Pusterla S., Previtali S., Marziali S., et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 5 4 (2004) 341-346
33. Yoon K.H., Wong A., Shakespeare T., et al. High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12 2 (2003) 112-116
34. Genvresse I., Luftner D., Spath-Schwalbe E., et al. Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. Eur J Haematol 68 2 (2002) 84-90
35. Shortell C.K., Ouriel K., Green R.M., et al. Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. J Vasc Surg 15 1 (1992) 158-165 [discussion: 165-6]
36. Miesbach W., Scharrer I., and Asherson R. Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 25 6 (2006) 840-844
37. Andrejevic S., Bonaci-Nikolic B., Bukilica M., et al. Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma, and antiphospholipid syndrome. Clin Exp Dermatol 28 2 (2003) 151-153
38. Muir D.F., Stevens A., Napier-Hemy R.O., et al. Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. Int J Cardiovasc Intervent 5 1 (2003) 44-46
39. Carter D., Olchovsky D., Yonath H., et al. Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 25 5 (2006) 756-758
40. Gonzalez Quintela A., Candela M.J., Vidal C., et al. Nonbacterial thrombotic endocarditis in cancer patients. Acta Cardiol 46 1 (1991) 1-9
41. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 6 (2001) 355-377
42. Soltesz P., Szekanecz Z., Vegh J., et al. Catastrophic antiphospholipid syndrome in cancer. Haematologia (Budap) 30 4 (2000) 303-311
43. Yamamoto T., Ito M., Nagata S., et al. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol 27 8 (2000) 2035-2037
44. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46 4 (2002) 1019-1027
45. Miesbach W., Scharrer I., and Asherson R.A. High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. Clin Rheumatol 26 1 (2007) 95-97
46. Finazzi G. The Italian registry of antiphospholipid antibodies. Haematologica 82 1 (1997) 101-105
47. Sciarra A., Stasi R., Stipa E., et al. [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma]. Recenti Prog Med 86 2 (1995) 57-62
48. Stasi R., Stipa E., Masi M., et al. Antiphospholipid [in Italian] antibodies: prevalence, clinical significance, and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost 70 4 (1993) 568-572
49. Palosuo T., Virtamo J., Haukka J., et al. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men-a nested case-control study. Thromb Haemost 78 4 (1997) 1178-1182
50. Sawamura M., Yamaguchi S., Murakami H., et al. Multiple autoantibody production in a patient with splenic lymphoma. Ann Hematol 68 5 (1994) 251-254
51. Becker J.C., Winkler B., Klingert S., et al. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 73 6 (1994) 1621-1624
52. Joseph R.E., Radhakrishnan J., and Appel G.B. Antiphospholipid antibody syndrome and renal disease. Curr Opin Nephrol Hypertens 10 2 (2001) 175-181
53. Lossos I.S., Bogomolski-Yahalom V., and Matzner Y. Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol 57 2 (1998) 139-143